A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis
Authors
Keywords
<em class=EmphasisTypeItalic >Cannabis sativa</em> L, Multiple sclerosis, CBD-cream, Inflammation, Oxidative stress
Journal
DARU-Journal of Pharmaceutical Sciences
Volume 23, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-22
DOI
10.1186/s40199-015-0131-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabinoids in Experimental Stroke: A Systematic Review and Meta-Analysis
- (2015) Timothy J England et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice
- (2015) A. Rahimi et al. NEUROSCIENCE
- Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
- (2014) Sabrina Giacoppo et al. MOLECULES
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis
- (2013) Shaher Duchi et al. JOURNAL OF NEUROIMMUNOLOGY
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production
- (2013) Sofia Fernanda Gonçalves Zorzella-Pezavento et al. MEDIATORS OF INFLAMMATION
- Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
- (2013) Wendy Swift et al. PLoS One
- Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
- (2012) Martin S. Weber et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment
- (2011) Sabine Lindquist et al. Multiple Sclerosis Journal
- Phytocannabinoids as novel therapeutic agents in CNS disorders
- (2011) Andrew J. Hill et al. PHARMACOLOGY & THERAPEUTICS
- Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
- (2010) Kalpana S. Paudel et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Cannabimovone, a Cannabinoid with a Rearranged Terpenoid Skeleton from Hemp
- (2010) Orazio Taglialatela-Scafati et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- Interaction between cytokines, cannabinoids and the nervous system
- (2010) Lucie Jean-Gilles et al. IMMUNOBIOLOGY
- Absence of PI3Kγ leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis
- (2010) David Henrique Rodrigues et al. JOURNAL OF NEUROIMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
- (2010) R. G. Pertwee et al. PHARMACOLOGICAL REVIEWS
- Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- (2009) Teresa Iuvone et al. CNS Neuroscience & Therapeutics
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- (2009) Sadiye Amcaoglu Rieder et al. IMMUNOBIOLOGY
- Cannabinoids and experimental models of multiple sclerosis
- (2009) Ilona Kubajewska et al. IMMUNOBIOLOGY
- Modulation of experimental autoimmune encephalomyelitis by endogenous Annexin A1
- (2009) Nikolaos Paschalidis et al. Journal of Neuroinflammation
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
- (2008) Barbara L.F. Kaplan et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
- The peripheral cannabinoid receptor knockout mice: an update
- (2007) N E Buckley BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid control of neuroinflammation related to multiple sclerosis
- (2007) D Baker et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR55: a new member of the cannabinoid receptor clan?
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More